Biomea Fusion (BMEA) News Today $7.41 +0.31 (+4.37%) (As of 12:04 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period We're A Little Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn RateNovember 13 at 6:35 AM | finance.yahoo.comAnalysts Set Expectations for Biomea Fusion FY2024 EarningsNovember 5, 2024 | americanbankingnews.comBiomea Fusion FY2024 EPS Estimate Raised by HC WainwrightBiomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Equities researchers at HC Wainwright raised their FY2024 earnings per share estimates for Biomea Fusion in a report issued on Thursday, October 31st. HC Wainwright analyst J. Pantginis now anticipates that the company will post earnings of ($3.97November 4, 2024 | marketbeat.comBiomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)November 1, 2024 | globenewswire.comTruist Financial Remains a Buy on Biomea Fusion (BMEA)October 31, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Biomea Fusion (BMEA)October 31, 2024 | markets.businessinsider.comBiomea Fusion, Inc.: Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate HighlightsOctober 31, 2024 | finanznachrichten.deBiomea Fusion's (BMEA) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $40.00 price objective on shares of Biomea Fusion in a research note on Thursday.October 31, 2024 | marketbeat.comBiomea Fusion Presents Preclinical Data Showing Icovamenib (BMF-219) Enhanced Effectiveness of GLP-1-Based Therapies and Introduces BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist CandidateOctober 30, 2024 | globenewswire.comBarclays Keeps Their Hold Rating on Biomea Fusion (BMEA)October 30, 2024 | markets.businessinsider.comBiomea Fusion price target raised to $11 from $9 at BarclaysOctober 30, 2024 | markets.businessinsider.comBarclays Increases Biomea Fusion (NASDAQ:BMEA) Price Target to $11.00Barclays lifted their price target on shares of Biomea Fusion from $9.00 to $11.00 and gave the company an "equal weight" rating in a research note on Wednesday.October 30, 2024 | marketbeat.comBiomea Fusion (NASDAQ:BMEA) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPSBiomea Fusion (NASDAQ:BMEA - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.91) earnings per share for the quarter, beating analysts' consensus estimates of ($0.94) by $0.03.October 30, 2024 | marketbeat.comBiomea Fusion Reports Q3 2024 Financial ResultsOctober 30, 2024 | msn.comBiomea Fusion Reports Third Quarter 2024 Financial Results and Corporate HighlightsOctober 29, 2024 | globenewswire.comBiomea Fusion options imply 6.1% move in share price post-earningsOctober 29, 2024 | markets.businessinsider.comBiomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Buy" from BrokeragesBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has earned an average recommendation of "Buy" from the twelve ratings firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation, eight have issued a buy recommendationOctober 28, 2024 | marketbeat.comBuy Recommendation for Biomea Fusion: Promising Clinical Developments of Icovamenib in Diabetes TreatmentOctober 22, 2024 | markets.businessinsider.comBiomea Fusion's (BMEA) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $40.00 price objective on shares of Biomea Fusion in a research note on Tuesday.October 22, 2024 | marketbeat.comBiomea Fusion announces approval of ‘icovamenib’ as INN for BMF-219October 21, 2024 | markets.businessinsider.comBiomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219October 21, 2024 | globenewswire.comBiomea Fusion, Inc. (NASDAQ:BMEA) Shares Purchased by Griffin Asset Management Inc.Griffin Asset Management Inc. raised its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) by 147.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 96,070 shares of the company's stock afterOctober 16, 2024 | marketbeat.comBiomea Fusion to Host Conference Call and Webcast on Wednesday, October 30th at 4:30 pm ET to Announce Our Lead Clinical Candidate, BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist and Preclinical Data Combining BMF-219 with a GLP-1 RA-Based TherapyOctober 15, 2024 | globenewswire.comSquarepoint Ops LLC Invests $237,000 in Biomea Fusion, Inc. (NASDAQ:BMEA)Squarepoint Ops LLC bought a new stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 52,628 shares of the company's stock, vaOctober 13, 2024 | marketbeat.comBiomea Fusion, Inc. (BMEA)October 12, 2024 | finance.yahoo.comBiomea Fusion (NASDAQ:BMEA) Stock, Insider Trading ActivityOctober 11, 2024 | benzinga.comBiomea Fusion (NASDAQ:BMEA) Raised to "Strong-Buy" at EF Hutton Acquisition Co. IEF Hutton Acquisition Co. I raised Biomea Fusion to a "strong-buy" rating in a report on Wednesday.October 10, 2024 | marketbeat.comBiomea Fusion to Present at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)October 7, 2024 | globenewswire.comRenaissance Technologies LLC Purchases Shares of 329,106 Biomea Fusion, Inc. (NASDAQ:BMEA)Renaissance Technologies LLC acquired a new position in shares of Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 329,106 shares of the company's stockOctober 5, 2024 | marketbeat.comIndependent Director of Biomea Fusion Michael J. Hitchcock Buys 200% More SharesOctober 3, 2024 | finance.yahoo.comBiomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of "Moderate Buy" by AnalystsBiomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eleven analysts that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating anOctober 3, 2024 | marketbeat.comInsider Buying: Biomea Fusion, Inc. (NASDAQ:BMEA) Director Purchases 10,000 Shares of StockOctober 2, 2024 | insidertrades.comBiomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by RODMAN&RENSHAWRODMAN&RENSHAW raised shares of Biomea Fusion to a "strong-buy" rating in a report on Thursday.September 28, 2024 | marketbeat.comTruist Securities Upgrades Biomea Fusion (BMEA)September 28, 2024 | msn.comBuy Rating Affirmed for Biomea Fusion with Promising BMF-219 Clinical and Regulatory DevelopmentsSeptember 27, 2024 | markets.businessinsider.comBiomea upgraded by analysts after FDA lifts clinical holdSeptember 27, 2024 | msn.comOppenheimer Sticks to Its Buy Rating for Biomea Fusion (BMEA)September 27, 2024 | markets.businessinsider.comPiper Sandler Remains a Buy on Biomea Fusion (BMEA)September 27, 2024 | markets.businessinsider.comFDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes CandidateSeptember 27, 2024 | finance.yahoo.comBiomea Fusion Sees Unusually Large Options Volume (NASDAQ:BMEA)Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) was the recipient of unusually large options trading activity on Friday. Traders bought 9,805 call options on the company. This represents an increase of 1,010% compared to the average volume of 883 call options.September 27, 2024 | marketbeat.comScotiabank Increases Biomea Fusion (NASDAQ:BMEA) Price Target to $41.00Scotiabank boosted their target price on Biomea Fusion from $21.00 to $41.00 and gave the stock a "sector outperform" rating in a research report on Friday.September 27, 2024 | marketbeat.comBiomea Fusion, Inc.: FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes TrialsSeptember 27, 2024 | finanznachrichten.deStocks See Support as Bond Yields Fall on Fed Rate Cut OptimismSeptember 27, 2024 | msn.comUS FDA lifts clinical hold on Biomea's diabetes trialsSeptember 27, 2024 | reuters.comBiomea Fusion Hold Rating: FDA Clearance and Increased Price Target Amid Cautious OptimismSeptember 27, 2024 | markets.businessinsider.comRodman & Renshaw Upgrades Biomea Fusion (BMEA)September 27, 2024 | msn.comBiomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock UpSeptember 27, 2024 | markets.businessinsider.comBiomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by Truist FinancialTruist Financial raised shares of Biomea Fusion from a "hold" rating to a "buy" rating and set a $54.00 price objective on the stock in a research note on Friday.September 27, 2024 | marketbeat.comFDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes TrialsSeptember 26, 2024 | globenewswire.comCessatech A/S (8GN.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.com Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! BMEA Media Mentions By Week BMEA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMEA News Sentiment▼0.710.54▲Average Medical News Sentiment BMEA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMEA Articles This Week▼23▲BMEA Articles Average Week Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABOS News OVID News BCAX News APLT News COGT News MESO News BCYC News AVBP News ARDX News PAHC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMEA) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomea Fusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomea Fusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
